PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Go back to PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 68.81 -0.49 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.30 | 52 Week High | $35.40 | |||
| Open | $67.81 | 52 Week Low | $4.03 | |||
| Day High | $70.08 | P/E | 7.32 | |||
| Day Low | $67.48 | EPS | $9.40 | |||
| Volume | 1,118,321 | |||||
